Navigation Links
Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
Date:8/2/2011

om the forward-looking statements include, but are not limited to, the following: the estimated human brain exposure of lorcaserin is an extrapolation that depends on the assumptions made and the particular human CSF and plasma and animal brain, CSF and plasma measurements used, and the estimate may differ depending on the analysis; the timing of regulatory review and approval is uncertain; the risk that data and other information related to Arena's research and development programs may not meet safety or efficacy requirements or otherwise be sufficient for regulatory approval; Arena's response to the CRL for the lorcaserin NDA or submission of a Marketing Authorization Application for regulatory approval of lorcaserin may not be submitted when anticipated, if at all; the FDA may request other information prior to or after Arena submits such response or approval of the lorcaserin NDA; unexpected or unfavorable new data; risks related to commercializing new products; Arena's ability to obtain and defend its patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; Arena's ability to obtain adequate funds; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; and satisfactory resolution of pending and any future litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements,
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... NEWBURY PARK, Calif. , Jan. 22, 2015 ... drive the continued consolidation of localization purchasing in 2015, ... According to a recent study by market ... studied chose a single-source solution for their translation and ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... addition of the "Microbiology Testing/Clinical Microbiology Market ... Global Forecast to 2019" report to their ... wide array of techniques for the detection of ...
(Date:1/22/2015)... Parenteral Drug Association (PDA) today announced the launch of its ... Future. The Manufacturing Science Program SM ... the ongoing focus PDA has on pharmaceutical and biopharmaceutical manufacturing. ... gaps in current manufacturing science as well as gaps that ...
Breaking Medicine Technology:Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 3PDA Launches Manufacturing Science Program(SM) 2PDA Launches Manufacturing Science Program(SM) 3
...  Bayer HealthCare is pleased to announce two employees have ... (HBA). They were honored at the annual HBA Woman ... May 3. Mary Puncochar, Area Sales Manager, ... Laura Schwieterman, Senior Brand Manager, U.S. Marketing, Bayer HealthCare ...
... Reportlinker.com announces that a new market research ...   Antithrombotic/Anticoagulant ... http://www.reportlinker.com/p0325493/Antithrombotic/Anticoagulant-Drugs-World-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication   ... Where are antithrombotic and anticoagulant ...
Cached Medicine Technology:Bayer Employees Named Rising Stars by Healthcare Businesswomen's Association 2Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 2Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 3Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 4Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 5Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 6Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 7Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 8Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 9Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 10Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 11
(Date:1/22/2015)... Lynchburg, Va. (PRWEB) January 22, 2015 Liberty ... Health Counseling (M.A.) program from the Council for ... The program, part of Liberty’s Center for Counseling & ... Hawkins, founding dean of the university’s new School of Behavioral ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located in ... number one best large hotel for families in the United ... annual Travelers’ Choice Awards. , TripAdvisor represents the world’s ... to millions of unbiased and honest traveler reviews. The best ...
(Date:1/22/2015)... 2015 VogueQueen is a seasoned and trusted ... many designers are thrilled to have it lead the wedding ... new collection of prom dresses for the global market. , ... strategic vision and he focuses on continuing the goal of ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... Among breast cancer patients, both chemotherapy and tamoxifen independently reduced ... breast, according to a study published online December 25 in ... risk reduction persisted for at least 10 and 5 years, ... developing cancer in the other breast is two to six ...
... genetic mutation already known to be more common in ... Hispanic and young African-American women with breast cancer, according ... mutation to date. , Researchers at the Stanford University ... reported the finding from a study of 3,181 breast ...
... taking things as they come, expert says , MONDAY, Dec. ... and social stress, and memories of lost loved ones can ... lead to seasonal blues during the holidays, says an expert ... expect difficult relationships to improve just because it,s Christmas are ...
... Dec. 24 QMed, Inc., (Nasdaq:,QMED) today announced that ... the last 30 business days, the bid price of ... per share requirement for,continued inclusion under Marketplace Rule 4310(c)(4) ... (D), the Company,will be provided 180 calendar days, or ...
... HARBIN, China, Dec. 24 /Xinhua-PRNewswire-FirstCall/ -- China Sky ... marketer and,distributor of pharmaceutical, medicinal and diagnostic products ... & Co., LLP as its independent,auditor, effective immediately. ... China Sky One Medical, Inc. stated, "We are ...
... Therapeutics Inc.,("Transition" or the "Company") (TSX: TTH; NASDAQ: ... US$5million milestone payment under its,global collaboration agreement with ... ELN ). The milestone payment was triggered by ... Alzheimer,s disease drug candidate, ELND005,(AZD-103), which was jointly ...
Cached Medicine News:Health News:Breast cancer gene mutation more common in Hispanic, young black women, Stanford/NCCC study finds 2Health News:Breast cancer gene mutation more common in Hispanic, young black women, Stanford/NCCC study finds 3Health News:Realistic Expectations Help Ward Off Holiday Depression 2Health News:QMed, Inc. Receives NASDAQ Letter 2Health News:China Sky One Medical Appoints Independent Auditor 2Health News:Transition Therapeutics Announces Milestone Payment from Elan 2
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
A straightforward, versatile approach to arthroscopically assisted pin placement in either the ankle or wrist....
... The BTA stat Test is ... the qualitative detection of bladder ... diagnosed with bladder cancer. This ... an aid in the management of ...
ThyroTest by ThyroTec, Inc. is a rapid immunoassay, similar to a rapid pregnancy test. By using 2 drops of blood from a finger stick and 5 drops of diluent, a qualitative TSH level is inicated in min...
Medicine Products: